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create a 17-amino acid extension sequence, as well as additional exons that become incorporated into the 5' and 3' ends ( Figure 1 ). In total, the NPIPB1 canonical gene model consists of 11 exons, of which 7 are shared with NPIPA members. All gene structures within the human reference genome have been renamed based on this classification according to Human Gene Nomenclature (HGNC) standards.
Conceptual translation of the two subtypes predicts very different, albeit related, protein structures ( Figure 1 ). The beginning of the NPIPB protein consists of an alternate amino acid start sequence "MVKLS" and contains three distinct types of amino acid repeats at the carboxy (C) terminal portion of the protein: namely, two copies of PLPPSA (each 5 repetitions), 12 repetitions of a MIISRHLPSV(C/S)(G/S)X(R/P)FHP motif, and 8 repetitions of a ((P/R)(K/E)PKRRR(AA/VG)DVEP) motif. In contrast, the NPIPA copies carry only the hexapeptide PLPPSA repeat, which is highly variable in copy number between both NPIPA and NPIPB paralogs. In contrast, the NPIPB-specific peptides (MIISRHLPSV(C/S)(G/S)X(R/P)FHP) and ((P/R)(K/E)PKRRR(AA/VG)DVEP) appear fixed at 12 and 8 copies, respectively, among all NPIPB duplicates ( Figure 1 ). It is interesting to note that a simple frameshift mutation (of TGAGCGTCTCTGCGGATTCCG) converts PLPPPSA to a MIISRHLPSV(C/S)(G/S)X(R/P)FHP motif, indicating that these two motifs originate from the same nucleotide sequence ( Figure S1 ). Phylogenetic reconstruction of the C-terminal repeat sequence indicates that the mature NPIPB gene was derived from NPIPA during the process of evolution in a stepwise manner by addition of different types of repeat sequences after the split from orangutan leading to human lineage. genes. The NPIPA and NPIPB structure is based on AF132984 and AB209632, respectively. Translation start (green) and stop (red flags) codons are indicated with respect to gene structure from the human reference genome. Protein structures for the 40 kDa NPIPA (C) and 95 kDa NPIPB (F) proteins are based on SMART search database using SMART normal and genomic tools (see Supplementary Table 1 for protein domain homology). The NPIPB gene differs from the classical NPIPA gene by the presence of additional exons at the N-and C-terminal regions, eight repeat sequences, an alternative start exon at the 5' region, and a long 5'UTR. There are, however, RT-PCR clones showing alternative splicing when compared to the classical NPIP, which is depicted in green (MFCCL). The repeat sequence composition within the 5'UTR (E) is based on RepeatMasker ( Figure S3 ).
Protein domain analysis (as well as experimental analysis; see below) suggests that the carboxy terminus may have a role in the localization and/or association of the morpheus gene family members to the cell cytoskeleton. Recent evidence indicates that the PLPP peptide region from the Kalirin8 protein, also known as Huntingtin-associated protein-interacting protein (HAPIP), is involved in RhoGEF activity by intra and intermolecular interaction with SH3 domains (10) (Figure S2 ). Although the predicted protein structure of the morpheus protein is quite unique, there is 19%, 27%, 16%, and 21% similarity to the amino (N) terminal region of melanoma inhibitory activity family, member 3 (MIA3) from mouse (NM_177389), marmoset 6 (XR_144690.1, XM_002764063), macaque (XM_001100730), and gibbon (XM_003265207), respectively. The NPIPB protein has similarity to HALZ, IRF, Hr1, to the N-terminal region of Amelogenin, and PLCXc in the C-terminal region. The shorter, NPIPA, 40 kDa protein has a significant level of similarity to HSA and IL2 in the N-terminal region (Figure 1 and  Supplementary Table 1) . We also predict potential phosphorylation sites, Sh3 and WW interaction sites at the C-terminal portion of the protein ( Figure S2) . Interestingly, our own phylogenetic analysis using the most rapidly evolving portion of LCR16a (n = 667 bp, Figure 2 ) (4) confirms a remarkable structured phylogenetic relationship between and within different primate species (Figure 2) . Focusing on the most rapidly evolving portion of the gene, we find that most great ape species have their own evolutionarily distinct set of morpheus genes. The NPIPB subfamily has expanded primarily within the human and chimpanzee lineages with specific branches increasing differentially. Human and chimpanzee NPIPA show a clear monophyletic origin with evidence of lineage-specific expansions in both branches. This dichotomy between NPIPA and NPIPB, however, is not predicted among the Asian apes. Only one complete copy of the NPIPB gene (see below) can be detected within the Asian apes and it appears to possess an incomplete gene structure; although, we cannot rule out technical problems associated with assembly of the reference genome for the Asian apes.
Comparative analysis of intergenic and intronic sequences indicates some radical, potentially functional, changes in the gene structure among different hominoids. We identified, for example, an Alu/ERV1 integration corresponding to the promoter region of NPIPB and the expansion of SINE/MIR, LINE/L2 repeats corresponding to the 5'UTR (untranslated region) of morpheus after the split of the Old World and New World monkey lineages (Figures 2, S3 and S4). Further comparative analysis of primate genomes and BAC sequence data suggested that the start codon from NPIPB emerged from noncoding DNA repetitive sequence. We find no evidence, for example, of an ATG start codon corresponding to the orthologous start position for NPIPB in either the genomes or BAC sequence from New World monkeys (Saimiri boliviensis (AC234805), Callithrix jacchus (AC202644)), Old World monkey (M. mulatta), or prosimian (M. murinus) (AC235773) ( Figure S6 ). Additionally, no splicing acceptor region is detected in macaque for exon 2 of the NPIPB gene. Combined, these data suggest that the NPIPB model emerged specifically within the ape lineage. We identified and sequenced multiple BACs carrying copies of morpheus from gibbon (N. leucogenys) and orangutan (P. pygmaeus). Four gibbon BACs (AC187943, AC166855, AC166597 and AC167295) showed evidence of a repeatrich 5'UTR and ATG start codon associated with the NPIPB model. Only one BAC (AC145401) in orangutan (mapping to ponABe2 chromosome 16 position 429612) contains the NPIPB 5'UTR (Figures 2 and S5) but this single NPIPB paralog does not possess a start codon consistent with canonical NPIPB model, suggesting that it is not capable of producing a functional NPIPB gene product. It is possible that this copy represents the ancestral locus from which African great ape copies of NPIP emerged.
Figure 2. Evolutionary relationships of morpheus gene family
A neighbor-joining phylogeny constructed from a multiple sequence alignment of the most rapidly expanded portion of the LCR16a core sequence (exon-intron structure of the 737 bp fragment is shown). Species names are indicated as: mmu gray mouse lemur (Microcebus murinus), cja marmoset, (Callithrix jacchus), rh Rhesus macaque (Macaca mulatta), pha baboon (Papio hamadryas) nle Gibbon (Nomascus leucogenys), ppy Orangutan (Pongo pygmaeus), ggo Gorilla (Gorilla gorilla), ptr Chimpanzee (Pan troglodytes), and hs Human (Homo sapiens). Sequences were extracted from reference genome assemblies with the exception of chimpanzee. Chimpanzee NPIPB genes are mapped based in the BACs, AC148621 for 3215-R AC148538, AC148838 for 6334827-Repeat, AC097271 for 10195-Repeat AC190226, AC097270 for 4954284, AC097327 for 639517059-Repeat, AC148839 for 11140, AC097332 for 29600364, AC190226 for 12131329-R, AC097328 for 4155-Repeat, AC097333 for 12125716-Repeat and M. murinus NPIPB in AC235773. The number next to the respective branch name indicates the position of each core sequence within each species. Bootstrap support (n = 500) is shown only for those branches that exceed 85% and genetic distances (number of substitutions per site) were computed using the Jukes-Cantor method (20) . All positions containing alignment gaps and missing data were eliminated (pairwise deletion option). Phylogenetic analyses were conducted in MEGA4 (21) .
II. Transcript Expression Analyses
Based on these morpheus gene models, we performed comparative RT-PCR from cDNA derived from various macaque and human tissue material. Macaque expression is predominantly testis (as well as weak thymus expression) in contrast to human, which shows a strong ubiquitous pattern of expression ( Figure 3 ). We quantified mRNA expression levels in human tissues by real-time quantitative PCR (RT-QPCR) and observed similar levels among the tissues (2-to 7-fold). Liver and heart showed the lowest, while thymus, testis and brain showed the highest levels of expression ( Figure 3 ). We cloned and sequenced a total of 56 RT-PCR products from HeLa and A549 cells and, based on unique sequence differences, assigned them to specific copies on human chromosome 16 ( Figure 4 ). We find that at least 13 of the 24 family members are transcribed revealing a remarkably complex pattern of 5' alternative splice forms (Figures 4 and  S9) . Combined with EST analysis, there is evidence for at least five alternative start exons for this gene family. We predict that some of these alternate first exons lead to a premature stop codon and nonfunctional transcript. For example, the PKD1-NPIP fusion transcripts are predicted to lead to a pseudogene as a result of a splicing frameshift. In total, about 80% of sequenced cDNA maintain an open reading frame consistent with the protein models described above while 20% (11/56 clones) show evidence of a frameshift. Although it is not always possible to unambiguously assign each transcript to a specific locus, there is evidence that some loci are producing both functional and nonfunctional transcripts due to alternative splicing ( Figure 4) .
Because of the higher levels of expression in the thymus and because immune response genes often show signatures of adaptive evolution (11-14), we investigated whether morpheus transcripts could be differentially regulated in various immune response pathways. We tested this by assessing morpheus total RNA expression levels of HeLa cell lines before and after stimulation with immunogenic agents. This included cytokines, such as interferons (α/β and γ), TNFα, and PAMPs (e.g., lypopolysaccaride (LPS), a mimic of pathogenic bacteria, and polyinosinic-cytidylic acid (pI:C), a mimic of viral RNA). We designed specific primer sets to assess three distinct regions of the morpheus gene model in order to span most of the major splice forms. Upon transfection of HeLa cells with pI:C (1µg/ml) for 6 hours, we observed a reproducible upregulation of morpheus mRNA levels of about sixfold ( Figure S10 ). None of the other immunogenic stimulant agents induced higher levels of mRNA (data not shown). Quantitative PCR analysis to show differential expression of morpheus gene family within human tissues is presented. Liver is used for normalization, which is the lowest NPIP expressing tissue. UBE1 is used for control. There is no significant enrichment of either long, (NPIPB), (95 kDa) or short, (NPIPA), (40 kDa) version of the morpheus mRNA copy present in any tissue tested. Morpheus is expressed relatively high level (approx. twofold) in testis and thymus both in human and macaque. The primers for real-time PCR were designed specifically for exon 6 and 8 NPIP_Exon6F, and NPIP_Exon8R (Supplementary Table 2 ). To distinguish both types of morpheus genes, the specific primer set for each copy is designed based on reference assembly.
Figure 4. High-resolution mapping of the morpheus gene family on a human chromosome
Mapping of the individual morpheus gene family members based on comparison of cDNA clone and human genome sequence. All genes and pseudogenes are assigned to either NPIPB or NPIPA subfamilies based on differences in the gene structure and named according to HGNC standards. Primers were designed for exon 1 and the beginning of exon 8 (before the repeat region of morpheus) and a total of 55 RT-PCR products were cloned and sequenced. The exon 1 primers were designed to amplify both canonical and alternative first exons as detected by 5'RACE and EST analysis (Supplementary Table 2 ). Transcripts corresponding to a likely pseudogene due to an incomplete open reading frame are shown in red. The position of each gene is depicted with a horizontal line and the (+/-) sign indicating the orientation of transcription (5' to 3') with respect to human chromosome 16. Clones that cannot be assigned to a unique genomic location are indicated by multiple arrows.
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III. Protein Analyses and Subcellular Localization
We investigated the subcellular localization of the protein by generating a series of rabbit polyclonal antibodies against one peptide that is specifically recognizing NPIPB; MP2:CSPEPKRRRVGDVEP, one peptide specific for NPIPA; N5:HGEKERQVSEAEENGK, and two peptides recognizing all types of morpheus: MP4:CTKVNRHDKINGKRKT, N8:CRMAAVQHRHSSGLPYW, respectively. We show that both N8 and N5 antibodies can specifically immunoprecipitate recombinant the GFP-NPIP fusion protein from HeLa cell lysate ( Figure S11 ). The specificity of the N8 antibody recognition is also confirmed by immunofluorescence analysis of transiently transfected HeLa cells with the GFP-NPIP fusion gene construct. Similarly, the specificity of MP4 and MP2 is determined by immunofluorescence analysis of overexpressed NPIPB flag-tagged at the N-terminus in HeLa cells (data not shown). The endogenous protein analysis using the N8 antibody gives specific band recognition at 95 kDa and 43 kDa in human tissue lysate when compared to mouse testis tissues (Bl6) ( Figure S12 ).
Analysis of the putative protein domain architecture predicts at least four nuclear localization signals (NLS) present in the middle and at C-terminal region of the NPIPB protein ( Figure S13 ). This is in contrast to NPIPA where there is no sequence similarity to any known NLS. To test the NLS prediction for the NPIPB protein, we successfully cloned partial copies of the two NPIPB genes (K1.3 (maps to chr 16:28671295) and K1.4 (maps to chr 16:22432624)), which differ only in exon 2 and the C-terminal region (Figures S14 and S15), into a mammalian expression vector (pM1-MT Roche) as well as the shared (seven-exon) region between NPIPA and NPIPB (c12 construct).
Despite multiple attempts, we were unable to clone a full-length copy of NPIP that included the entire C-terminal repeat region of the gene model. Transient overexpression of NPIPA constructs, whether tagged N-terminally with GFP or flag, were primarily localized to the nucleus in HeLa cells ( Figure 5 ). There is a partial localization around the periphery of the nucleus but the majority of the signal localizes within the nucleus. In contrast, the K1.3 clone of NPIPB localizes exclusively to the nucleus while the K1.4 construct, corresponding to the other NPIPB subtype, shows signal primarily in the cytoplasm ( Figure 5) . Notably, the shared NPIPA/NPIPB gene model construct, c12, clearly aggregates around the nuclear periphery ( Figure S16 ). The major difference between NPIPB and c12 is the presence of additional 5' and 3' exons ( Figure 1 ), which are not present in c12 ( Figure S14 ). c12 also differs from GFP Flag-NPIP by lacking the NPIP-specific exon 5 and the repeat sequence at the C-terminal region ( Figure  S14 ).
Combined, these findings suggest that the C-terminal portion of NPIPB is required for the proper localization of the morpheus protein to the nucleus. Although, no NLS was predicted for NPIPA, exon 5 may contain signals for proper localization of the NPIPA protein around the nucleus. Additionally, we have observed a proportion of the cells having cytosolic localization when the K1-4 construct is overexpressed. The unpredicted subcellular localization of the NPIPB type K1-4 construct shows that the presence of exon 2 and the C-terminal repeat sequence may be important in this regard, because it is the only place where the two constructs differ (Figures S14 and S15). It could also be possible that single amino acid substitutions observed within K1-3 and K14 may be responsible but this needs to be confirmed by further functional analysis. The immunofluorescence analysis above was also confirmed by western blot analysis ( Figure 6 ). We find that the 95 kDa band is detected only in nuclear/cytoskeleton/insoluble fraction consistent with the protein domain analysis showing that the N-terminal portion of the 95 kDa NPIPB protein has a domain structure similar to HALZ and IRF transcription factors. In addition, immunohistochemistry analyses using MP2 antibodies show that the endogenous NPIPB protein localized primarily within the nucleus in HeLa cells ( Figures 5, 6 and S17; see below). In a recent screen for B cell lymphoma-associated antigens, Cha and colleagues, unknowingly cloned four different constructs corresponding to a specific auto-antibody fraction of the isolated IgG purified from both treated and normal individuals (15) . Our detailed analysis shows that, in fact, clones FL-aa-4-1, FL-aa-4-2, FL-aa-4-3, and FL-aa-4-4 correspond to the Cterminal repeat region of the NPIPB protein. To confirm these findings, we transiently overexpressed the morpheus gene construct K1-3 in HeLa cells and co-stained transfected constructs with MP2 and MP4 antibody together with an isolated IgG fraction from a healthy donor. We found that the isolated human IgG from a healthy adult donor can specifically recognize NPIPB genes K1-3 ( Figure S18 ). 
IV. Stable Transfection Analysis
To characterize functional properties of morpheus proteins in vivo, and toxicity of overexpression of morpheus, we generated stable cell lines expressing the recombinant morpheus protein in mouse embryonic fibroblast (MEF) cells under the control of a Tet-Off inducible gene expression system. In the Tet-Off inducible gene expression system, cells were grown in the presence of tetracycline homolog doxycyline, and upon depletion of doxycyline, synthesis of recombinant morpheus protein is induced. Immunohistochemistry analyses of MEF cells that are stably expressing the morpheus gene (NPIP) under the control of Tet-Off promoter system show no or trace amounts of protein accumulation in doxycyline depleted cells for 24 hours unless the cells are transfected with pI:C using the Lipofectamine® 2000 transfection system (Invitrogen). This suggests that the recombinant morpheus protein might be degraded immediately in mouse cells. Upon transfection of NPIP-MEF cells with pI:C (1 µg/ml) for 6 hours, the morpheus protein is detected in the periphery of the nucleus and nuclear membrane similar to the results reported by Johnson and colleagues (5) (Figure 7 ). The total ratio for protein accumulation after transfection within MEF cell population was approximately 10-15%, potentially linked to transfection efficiency. We repeated the experiment using another morpheus-specific antibody (N5) and unrelated gene construct (luciferase gene) with similar results under the same conditions (data not shown). 
DISCUSSION
The morpheus gene family is one of the most rapidly evolving gene families to have emerged during human-great ape evolution (5) . In this study, we attempted to systematically characterize differences in expression, structure, and subcellular localization for major isoforms in order to gain insight into its evolution and potential function. Cloning and sequencing of RT-PCR products of the morpheus family showed that at least 13 of 25 copies in the human genome are actively transcribed in cultured human cell lines (HeLa and A549 cells). Our gene structure analysis suggests that members of the gene family may be operationally divided into two distinct subgroups: NPIPA and NPIPB.
The NPIPA subfamily, as originally reported by (5), is simpler in structure consisting of eight exons, including a diagnostic in-frame exon, "exon 5". Members of the second group, NPIPB (or morpheusB), are typically larger (10 exons), are transcribed by an alternate promoter, and possess a repeat-rich 5'UTR as well as additional 3' exons, including three distinct repeat sequences at the C-terminal portion of the gene. Comparative sequence analyses predict an expansion of the NPIPB subtype within great apes after the split from the orangutan lineage. This 16 rapid expansion of the NPIPB gene coincided with the emergence of a start codon (first exon) and numerous retrotransposition events within the 5' and 3' ends of the gene (Figures 2 and S5) . Since no functional NPIPB gene is detected within the New World or Old World monkey genomes, we suggest that the NPIPB subtype derived from duplication of NPIPA followed by the accumulation of numerous structural and single-basepair variants. In particular, the insertion of an AluY element near the C-terminus followed by a frameshift mutation led to the evolution of an entirely new amino acid repeat motif, PKRRRxxDVEP, associated specifically with the NPIPB subfamily.
Transcripts from both morpheus subtypes are expressed widely in all human tissues in contrast to other primates (e.g., macaque), which show a much more restricted pattern of expression (Figure 3) . If the macaque expression profile is considered ancestral, our analysis suggests that the morpheus gene family evolved from testis-and thymus-specific mRNA expression to a ubiquitous pattern in concert with its expansion in copy number. It is possible that the accumulation of common repeats near the 5'UTR and/or the juxtaposition of novel segmental duplications facilitated this broader expression profile in the ape lineage as has been observed for other gene families (16) (17) . Despite its broad expression profile in humans, Homan and colleagues identified NPIP as one of two gene families highly expressed in the macula of the retina (18) where its transcriptome abundance in photoreceptors is second only to that of the opsin genes. They suggested the gene family as a potential candidate for age-related macular degeneration.
The NPIPA protein was originally reported to localize to nuclear membranes where it potentially interacted with nuclear pore proteins (5) . In this study, we generated polyclonal antibodies against peptide sequences specific to both NPIPA and B subtypes. Predicted protein domain analyses, subcellular localization experiments, and overexpression studies confirm a translated product that primarily localizes to the nucleus or its periphery. Interestingly, actively transcribed members of the NPIPB subfamily localize predominantly to the nucleus in human cells and we show that the C-terminal region of the NPIPB protein is important for this nuclear localization. It is possible that these rapid changes in the morpheus protein structure evolved to direct subcellular trafficking between the cytosol and the nucleus. Surprisingly, we also find that healthy humans produce an auto-antibody against the Cterminal of NPIPB proteins ( Figure S18 ), confirming previous findings although the authors did not associate the target with NPIP (15) . Recognition of self-antigens in human autoimmune diseases involves both T and B cell responses and may suggest a role for NPIP genes in immunity or autoimmunity. In this light, it is noteworthy that when stably transfected NPIP-MEF cells are exposed to pI:C-a known immunostimulant for TLR3-the morpheus protein localizes to a vesicular structure and accumulates around the nuclear membrane. In addition, the N-terminal region of the long (95 kDa) morpheus protein has significant similarity to a transcription factor binding protein HALZ, which is a homeobox-associated protein, and IRF7, which is an interferon regulatory protein (Figure 1 and Supplementary Table 1) . One possibility may be that the morpheus protein is activated by the pI:C-dependent immune response pathway. Upon activation, the morpheus protein is modified (phosphorylated or glycosylated) and transported to the nucleus where it is predicted to maintain its function. The morpheus protein may first need to be stabilized by post-translational modification and later transported to the nucleus with the help of other, as of yet unknown, human-specific factors.
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MATERIAL AND METHODS
RT-PCR
cDNA was prepared using the RT-PCR kit (Roche) according to the manufacturer instructions. Total RNA used for cDNA preparation was extracted from Rh (macaque) tissues, HeLa and A549 cells (RNA easy, Qiagen), and the total RNA for hs (human) tissues (Clontech). RT-PCR products prepared using the cDNA from the cells were cloned to the pGEM-T-Easy vector. Colony PCR was used to identify positive clones. These were selected for mini-prep plasmid isolation and sequencing. In total, 96 colonies from A549 and 81 clones from HeLa cells were analyzed. UBE1 are used as positive controls. PCR was performed in 20 µl reactions composed of 0.8 µl of a 10 µM dilution of the forward primer and reverse primer, 10 µl of Roche (11636103001) PCR Master Mix. The following PCR conditions were used: 1 min at 94°C, followed by 38 cycles at 94°C for 30 sec, 55°C 30 sec, and 72°C for 30 sec followed by 7 min at 72°C.
Real-time PCR
Morpheus splice variants were detected by a quantitative PCR assay using the LightCycler SYBR Green System (Roche) with exon 6 and 8 primers (see Supplemental Table 2 for a complete list of oligonucleotides used). cDNA was synthesized using mRNA prepared from lymphoblast cell lines. The amount of measured transcripts was normalized to the amount of the GAPDH and UBE1 transcript. The following real-time PCR conditions (C) were used: 3 min at 95°C, followed by 50 cycles at 95°C for 15 sec, 55°C 20 sec, and 72°C for 20 sec.
Stable cell line preparation
We generated an inducible Tet-Off cell line stably expressing morpheus C5 (Classical NPIP), C3 and C4 (mutated versions as control originating from clone names 13). CLuc luciferase was used as positive control for transfection and to measure inducibility. Cells are Tet-Off so they are growing in the presence of 2 µg doxycycline that is the homolog of tetracycline; G418 (400 µg/ml) was used to select and maintain the reporter gene carrying cells (for inducibility). Hygromycin (50 to 200 µg/ml) is used to select the transfected cells and maintain the cells carrying the transfected construct such as morpheus C5 and luciferase CLuc. The MEF cells are transfected with the respective constructs and kept under a continuous feeding and selection process. Tet-Off MEF cells were purchased from Clontech.
Immunoprecipitation
Cells are transfected with either GFP or GFP-NPIP constructs. 24 hours after transfections, cells are lysed with 1 ml of RIPA buffer; 15 µl of this lysate is separated for western blot analysis. 60 µl of protein A beads (Amersham) are added to the lysate and incubated for 1 hour at 4°C with inversion. The slurry is spun down for 1 min at 4°C. The pre-cleared lysate is incubated with 2.5 µg of primary NPIP antibodies (N5 and N8) or preimmune N8. The antibody and lysate mixture is incubated for 1 hour at 4°C with inversion. 60 µl of 50% protein A beads are added on the antibody-lysate mixture and left at 4°C overnight. The tubes are spun down (1 min full speed) and Health to NISC and JCM. We would like to thank Cezmi A. Akdis for his technical support and Tonia Brown for feedback on the manuscript. EEE is an investigator of the Howard Hughes Medical Institute.
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